• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA sets advisory meeting date for Brainstorm’s ALS cell therapy

cafead

Administrator
Staff member
  • cafead   Jun 06, 2023 at 04:22: PM
via The biotech will get another chance to make a case for its drug NurOwn during a Sept. 27 meeting of cell, tissue and gene therapy experts.

article source